Jingfang granules inhibiting LPS-induced acute lung injury via regulating linoleic acid and arachidonic acid metabolism pathway
PLOS One · 16.01.2026 · 21 (1) · e0340858
DOI: 10.1371/journal.pone.0340858 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 16.01.2026. Verfasst von Yuqi Fu und 12 weiteren Autor:innen. Beteiligte Einrichtung: State key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, National Chinmedomics Research Center, National TC…. Hauptthemen laut MEDLINE: Arachidonic Acid, Linoleic Acid, Acute Lung Injury, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizontal project named “Systematic analysis and quality upgrade of the effectiveness of Jingfang granules based on metabolomics” of Lunan Pharmaceutical Grou…, Key Research and Development Project of Hainan Province.
Abstract (Originalsprache)
Acute lung injury (ALI) is a severe clinical syndrome with high mortality. Jingfang Granules (JFG), a modern formulation of the traditional Chinese medicine (TCM) compound Jingfang Baidu Powder, has been widely used to treat ALI. However, its protective effects and underlying mechanisms in ALI remain poorly understood. This study is based on a lipopolysaccharide (LPS)-induced ALI rat model, which was intervened with low, medium, and high dose of JFG. We carried out metabolomic analysis and identified 12 blood metabolites, the levels of core metabolites were regulated under JFG intervention, including L-Carnitine, Citric acid, Taurocholic acid, Arachidonic acid (AA), and Linoleic Acid (LA). Besides blood metabolites, 11 urine metabolites were also callback under JFG intervention, including Valine, Citric acid, L-Phenyalalanine, and Leukotriene B4, mainly involving the LA metabolism, AA metabolism, and phenylalanine, tyrosine and tryptophan biosynthesis. Comprehensive analysis shows that the restored enrichment pathways are mainly concentrated in inflammatory response, amino acid metabolism, and fatty acid metabolism. These findings reveal the potential mechanism of JFG in LPS-induced ALI, and its pathway nodes facilitate rapid translation from laboratory to clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Metabolomics Laboratory,…
- State Key Laboratory of Dampness Syndrome, The Second Affiliated Hospital Guangzhou University of Chinese Medicine, Guangzhou, China.
- State key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co. Ltd., Linyi, China.
ORCID-Profile: Yuqi Fu
Förderung
- Horizontal project named “Systematic analysis and quality upgrade of the effectiveness of Jingfang granules based on metabolomics” of Lunan Pharmaceutical Grou…
- Key Research and Development Project of Hainan Province
Zitieren
APA
Fu, Y., Liu, L., Yan, G., Yang, L., Zhang, G., Kong, L., Guan, Y., Sun, H., Guan, Y., Liu, C., Sun, Y., Han, Y., & Wang, X. (2026). Jingfang granules inhibiting LPS-induced acute lung injury via regulating linoleic acid and arachidonic acid metabolism pathway. PLOS One, 21(1), e0340858. https://doi.org/10.1371/journal.pone.0340858
Vancouver
Fu Y, Liu L, Yan G, Yang L, Zhang G, Kong L, et al. Jingfang granules inhibiting LPS-induced acute lung injury via regulating linoleic acid and arachidonic acid metabolism pathway. PLOS One. 2026;21(1):e0340858. doi:10.1371/journal.pone.0340858
BibTeX
@article{Fu2026,
author = {Fu, Yuqi and Liu, Lei and Yan, Guangli and Yang, Le and Zhang, Guimin and Kong, Ling and Guan, Yu and Sun, Hui and Guan, Yongxia and Liu, Chang and Sun, Ye and Han, Ying and Wang, Xijun},
title = {Jingfang granules inhibiting LPS-induced acute lung injury via regulating linoleic acid and arachidonic acid metabolism pathway},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {1},
pages = {e0340858},
doi = {10.1371/journal.pone.0340858}
}
EUVIMED